CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing Luzhu Biotechnology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing Luzhu Biotechnology Co Ltd
Phone: +86 1061568563p:+86 1061568563 BEIJING, BEJ  China Ticker: 24802480
Business Summary
Beijing Luzhu Biotechnology Co Ltd is a China-based company primarily engaged in the research, development and production of vaccines and therapeutic biologics. The Company is also engaged in the development of innovative human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Company's products include clinical-stage product candidates and pre-clinical-stage product candidates. The core product LZ901 is mainly used to prevent shingles caused by the varicella-zoster virus in adults aged 50 years and above. The Company mainly conducts its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, General Manager JianKong 59 6/18/2022 7/1/2002
Executive Vice Chairman of the Board, Deputy General Manager XianminJiang 60 6/18/2022 2/1/2002
Chief Financial Officer, Head - Global Capital Markets HuiZhang 54 6/1/2021 6/1/2021
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 148 (As of 6/30/2024)
Outstanding Shares: 202,449,032 (As of 6/30/2024)
Stock Exchange: HKG
Fax Number: +86 1061567093


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025